Korea United Pharm Inc. announced on the 12th that it hosted a delegation from Malaysia's Ministry of Health, Ministry of Science, Technology and Innovation, National Pharmaceutical Regulatory Agency, and Malaysian Investment Development Authority to discuss research and production cooperation in the pharmaceutical industry and to expand the pharmaceutical supply chain, aiming to explore the Malaysian market.

The meeting, held on the 11th at the United Yeoksam Building, was attended by 10 officials from various Malaysian government departments. The discussions focused on comprehensive cooperation measures such as drug registration, procurement, and investment cooperation for local production.

Korea United Pharm Inc. introduced its product lineup, which focuses on anticancer drugs and improved new drugs (new drugs that enhance existing ones), and explored the possibility of expanding supply based on the pharmaceuticals currently registered and exported in Malaysia.

Through this consultation, Korea United Pharm Inc. expects to strengthen the recognition of its products within Malaysia and secure opportunities to enter markets in neighboring countries based on intergovernmental cooperation. Furthermore, it is anticipated to serve as a bridgehead for expanding global partnerships in the fields of anticancer drugs and improved new drugs.

Popular News